Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
89.82
-0.96 (-1.06%)
At close: Oct 12, 2026, 4:00 PM EDT
90.95
+1.13 (1.26%)
After-hours: Oct 12, 2026, 4:27 PM EDT

Rhythm Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,1847,1433,4402,7171,641502
Market Cap Growth
-7.11%107.64%26.64%65.56%227.08%-61.83%
Enterprise Value
5,9636,9873,3972,4191,295176
Last Close Price
90.78107.0455.9845.9729.129.98

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
26.1237.6526.4435.0969.42159.06
PB Ratio
60.6626.4620.9116.006.211.77
P/TBV Ratio
63.8953.41221.1716.696.401.80

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
25.2036.8226.1031.2454.7955.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.510.420.690.630.290.01
Net Debt / Equity Ratio
-1.02-1.02-1.26-0.99-0.97-1.03
Net Debt / EBITDA Ratio
1.111.451.210.921.441.73
Net Debt / FCF Ratio
2.082.371.821.241.472.00
Asset Turnover
0.590.440.360.220.070.01
Inventory Turnover
1.070.880.981.611.41-
Quick Ratio
3.003.922.945.278.536.81
Current Ratio
3.454.413.245.588.907.10
Return on Equity (ROE)
-117.05%-90.45%-155.91%-85.10%-66.05%-30.89%
Return on Assets (ROA)
-30.96%-27.51%-29.84%-32.22%-31.45%-41.15%
Return on Capital Employed (ROCE)
-64.00%-51.30%-62.50%-66.40%-52.30%-59.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.35%-2.75%-7.58%-6.80%-11.04%-13.88%
FCF Yield
-1.70%-1.63%-3.31%-5.01%-10.59%-29.19%
Buyback Yield / Dilution
-8.09%-6.54%-5.76%-10.65%-5.08%-12.40%
SEC Filings: 10-K · 10-Q